{"drugs":["Baytet","HyperTET S\/D","Tetanus Immune Globulin"],"mono":{"0":{"id":"599270-s-0","title":"Generic Names","mono":"Tetanus Immune Globulin"},"1":{"id":"599270-s-1","title":"Dosing and Indications","sub":{"0":{"id":"599270-s-1-4","title":"Adult Dosing","mono":"<ul><li><b>Tetanus:<\/b> 3000 to 6000 units (30 to 300 units\/kg) IM given once has been used to treat patients with early symptoms of tetanus<\/li><li><b>Tetanus; Prophylaxis:<\/b> 250 units IM given once<\/li><\/ul>"},"1":{"id":"599270-s-1-5","title":"Pediatric Dosing","mono":"<ul><li><b>Tetanus; Prophylaxis:<\/b> (age 7 yr or greater) 250 units IM given once<\/li><li><b>Tetanus; Prophylaxis:<\/b> (age less than 7 yr) 4 units\/kg IM or 250 units IM given once<\/li><\/ul>"},"3":{"id":"599270-s-1-7","title":"Indications","mono":"<b>FDA-Labeled Indications<\/b><ul><li>Tetanus<\/li><li>Tetanus; Prophylaxis<\/li><\/ul>"}}},"3":{"id":"599270-s-3","title":"Contraindications\/Warnings","sub":{"1":{"id":"599270-s-3-10","title":"Precautions","mono":"<ul><li>hypersensitivity to immune globulin products<\/li><li>patients with IgA deficiency<\/li><li>thrombocytopenia or other contraindication to IM injections<\/li><\/ul>"},"2":{"id":"599270-s-3-11","title":"Pregnancy Category","mono":"C (FDA)<br\/>"},"3":{"id":"599270-s-3-12","title":"Breast Feeding","mono":"<ul><li>WHO: Compatible with breastfeeding.<\/li><li>Micromedex: Infant risk is minimal.<\/li><\/ul>"}}},"4":{"id":"599270-s-4","title":"Drug Interactions","sub":{"2":{"id":"599270-s-4-15","title":"Moderate","mono":"<ul><li>Measles Virus Vaccine, Live (probable)<\/li><li>Mumps Virus Vaccine, Live (probable)<\/li><li>Rotavirus Vaccine, Live (probable)<\/li><li>Rubella Virus Vaccine, Live (probable)<\/li><li>Smallpox Vaccine (probable)<\/li><li>Varicella Virus Vaccine (probable)<\/li><\/ul>"}}},"5":{"id":"599270-s-5","title":"Adverse Effects","mono":"<b>Common<\/b><br\/><b>Dermatologic:<\/b>Injection site pain<br\/><b>Serious<\/b><ul><li><b>Immunologic:<\/b>Anaphylaxis (rare)<\/li><li><b>Renal:<\/b>Nephrotic syndrome (rare)<\/li><li><b>Other:<\/b>Angioedema (rare)<\/li><\/ul>"},"6":{"id":"599270-s-6","title":"Drug Name Info","sub":{"0":{"id":"599270-s-6-17","title":"US Trade Names","mono":"<ul><li>Baytet<\/li><li>HyperTET S\/D<\/li><\/ul>"},"2":{"id":"599270-s-6-19","title":"Class","mono":"Immune Serum<br\/>"},"3":{"id":"599270-s-6-20","title":"Regulatory Status","mono":"RX<br\/>"},"4":{"id":"599270-s-6-21","title":"Generic Availability","mono":"No<br\/>"}}},"7":{"id":"599270-s-7","title":"Mechanism Of Action","mono":"Systemic: Following intramuscular injection, tetanus immune globulin provides immunity to those individuals who have low or no immunity to the toxin produced by the tetanus organism, Clostridium tetani. The antibodies act to neutralize the free form of the powerful exotoxin, tetanospasmin , produced by this bacterium .<br\/>"},"9":{"id":"599270-s-9","title":"Administration","mono":"<ul><li><b>General Information<\/b><br\/>for IM use only; do not give IV or intradermally<br\/><\/li><li><b>Intramuscular<\/b><br\/><ul><li>give deep IM injection in deltoid muscle or anterolateral thigh area<\/li><li>avoid gluteal area if possible due to proximity to sciatic nerve; if gluteal area must be used, avoid central region<\/li><\/ul><\/li><\/ul>"},"10":{"id":"599270-s-10","title":"Monitoring","mono":"clinical signs and symptoms of tetanus<br\/>"},"11":{"id":"599270-s-11","title":"How Supplied","mono":"<b>HyperTET S\/D<\/b><br\/>Intramuscular Solution: 250 U<br\/>"},"13":{"id":"599270-s-13","title":"Clinical Teaching","mono":"<ul><li>Advise patient to avoid vaccines for 3 months after administration of tetanus immune globulin.<\/li><li>This drug may cause injection site pain.<\/li><li>Instruct patient to report clinical signs\/symptoms of tetanus.<\/li><\/ul>"}}}